Table 4.
Quartile 2 vs. Quartile 1 239–284.60 vs ⩽238.95 |
Quartile 3 vs. Quartile 1 284.61–341.85 vs ⩽238.95 |
Quartile 4 vs. Quartile 1 ⩾341.9 vs. ⩽238.95 |
||||
---|---|---|---|---|---|---|
OR (95% CI) | p | OR (95% CI) | p | OR (95% CI) | p | |
cr-PWV | ||||||
Unadjusted | 0.645(0.264–1.579) | 0.337 | 1.390(0.980–1.970) | 0.065 | 1.260(1.000–1.588) | 0.050* |
Model 1 | 0.534(0.207–1.379) | 0.195 | 1.515(1.058–2.171) | 0.023* | 1.322(1.045–1.672) | 0.020* |
Model 2 | 0.453(0.005–1.241) | 0.123 | 1.781(1.156–2.744) | 0.009** | 1.259(0.942–1.681) | 0.019* |
Notes: Data were presented as ORs (per SD increase in uric acid level) and corresponding 95% CIs. In the logistic regression model, cr-PWV (PWV ⩾ 8.76m/s vs. PWV < 8.76 m/s) were treated as the dependent variable.
Model 1: adjusted for age, gender; Model 2: adjusted for age, gender, DM, current smoking, MetS, DBP, SBP and levels of TC, TG, HDL-C, LDL-C and Cr.
: p < 0.05.